Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Warsaw, Poland. Currently we are looking for Real World Evidence Specialist, a member of Country Medical Affairs Team responsible for scientific evidence & data generation plans & activities across therapeutic areas and along product life cycle. RWE Specialist will be responsible for developing and implementing the Country Medical Affairs product-related scientific data generation plan & vision in support of the Country and … Read more
Boston, MA, US. The Manager, US Health Economics and Outcomes Research is an entry level role on the US HEOR Real World Evidence (RWE) Team, based out of our Boston Headquarters. The Manager, US HEOR RWE leads the submission and assumes project owner status of US HEOR material within the internal Medical, Legal, and Regulatory Review process (MMR). This individual … Read more
Foster City, CA / Raleigh, NC, US. Other location: Parsippany, NJ, US. The Real-World Evidence (RWE) function at Gilead is part of the Clinical Data Sciences (CDS) group within the Clinical Development organization and aims to unlock the power of Real-World Data (RWD) to help transform innovations to life-changing medicines for patients. The Senior Director, RWE Innovation Methods and External … Read more
Europe. We are seeking highly qualified candidates to fill the position: Global Oncology HEOR & Payer Evidence Generation, Senior Manager (m/f/x). The Position: The Senior Manager, Global Health Economics Outcomes Research (HEOR) and Evidence Generation reports to the Senior Director Global HEOR asset leader and will work cross-functionally to implement HEOR and evidence generation projects. The person will work with … Read more
Barcelona, Spain. We are looking for a quantitative epidemiologists, bioinformaticians, health informaticians, biomedical data scientists, clinicians/pharmacologists, bio-statisticians or related fields with a strong desire to learn and expand their abilities into the analysis of Real World Evidence (RWE). The role holder will be a subject matter expert on the use of Real World Data and its capabilities in the use of RWD. The … Read more
Germany. A Research Consultant (RC) in real-world evidence (RWE) will be responsible for conducting RWE studies, for example retrospective database studies, including descriptive and analytic studies such as drug utilization, resource utilization, natural history of disease, comparative effectiveness, and safety with our clients from the pharmaceutical industry. The role is associated with day-to-day tasks in project design and conduct/management as well as … Read more
Beijing / Shanghai, China. RWE is increasingly important in China. Takeda China Medical has conducted several real-world studies (RWS). We hope the candidate provides HEOR&RWE and TAs with their experience and technical support. Key roles & responsibilities of Accelerator: 1. To learn China’s RWD resources and RWE development (overall picture such as Data status).2. To share RWE experience of candidate’s … Read more
Petaling Jaya, Malaysia / Bangkok, Thailand. Other location: Jakarta, Indonesia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, … Read more
Home-based, UK. Cencora has an ongoing need for an experienced Health Economic Modeler to join its Market Access and Healthcare Consulting team based in Europe. This is a remote opportunity based in the United Kingdom. Please apply if you are interested in being considered for full-time opportunities to join our team and support in the listed areas below: Position … Read more
Munich, Germany. We are seeking highly qualified candidates to fill the position: Global Oncology HEOR & Payer Evidence Generation, Senior Manager (m/f/x). The Position: The Senior Manager, Global Health Economics Outcomes Research (HEOR) and Evidence Generation reports to the Senior Director Global HEOR asset leader and will work cross-functionally to implement HEOR and evidence generation projects. The person will work … Read more
Shanghai, China. As part of the industry-leading global RWE solution, the IQVIA China Real-World Solution team is a young, energetic and fast-growing team consists of master and PhD level researchers/consultants, with strong academic background and working experience in economic modeling, value-evidence strategy & communication, value dossiers, network meta-analyses, and real-world studies either based on chart review or database analysis. In … Read more
Japan. RWE and Evidence excellence is responsible for providing strategic oversight and guidance as well as operational support on observational research/ real-world data & evidence initiatives that are pursued by internal teams, such as the Medical Affairs teams. The incumbent must have deep knowledge and extensive experience with Real-world Data (RWD) and Observational Research (OR)/ RWE generation, to partner with … Read more
Petaling Jaya, Malaysia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement … Read more
Mississauga, Canada. The Senior Director, Market Access will be responsible for leading, developing, championing and overall execution of reimbursement, negotiation and pricing strategies for Alexion Canada and managing the relevant relationships with public payers, government officials, hospital pharmacies, private payers, and other external partners across the Alexion portfolio. Reporting to the General Manager of Alexion Canada, the Senior Director, Market … Read more
Shanghai, China. Major Responsibilities: Cooperate with PVU to determine the clinical value, patient value and product value proposition of UCB products in the Chinese market based on medical evidence, and complete various tasks at the execution level. Cooperate with PVU to design and execute pharmacoeconomic studies, patient outcome studies, disease burden studies, RWE studies, etc. of UCB products to ensure timely and efficient completion of the … Read more
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Sempre attivo
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.